NCT00221403View on ClinicalTrials.gov

Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders

PHASE3CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Bipolar Disorder
Interventions
DRUG

Risperidone oral solution

liquid, BID dosing.

DRUG

Valproate Oral Solution

liquid, BID dosing.

OTHER

Placebo

liquid, BID dosing.

Trial Locations (2)

45267

Cincinnati Children's Hospital Medical Center, Cincinnati

53201

Children's Hospital of Wisconsin, Milwaukee

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT00221403 - Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar Disorders | Biotech Hunter | Biotech Hunter